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Abstract
Objectives: The inspiration of cobalt containing dust leads to various respiratory symptoms, including asthma and interstitial 
lung disease. Occupational asthma caused by cobalt chloride has been diagnosed in a 35-year-old patient, who worked as 
a diamond polishing disc former. The patient presented a 2-year history of dyspnea, cough and symptoms of rhinitis. 
Materials and Methods: The patient underwent a medical history interview, skin prick tests with common and occupational 
allergens (cobalt and nickel chloride), and pulmonary function testing both before and after the nasal provocation with 
0.05% cobalt chloride. Additionally, the authors analyzed morphological and biochemical changes before and after the 
speciﬁc nasal challenge test. Cell proliferation analysis was also carried out. Results: Skin prick tests (SPTs) with common 
environmental allergens were found to be negative, while SPTs with cobalt chloride were positive for all applied solutions. 
The provocation with cobalt chloride caused a signiﬁcant increase in the proportion of eosinophils, basophils and albumin 
during the late allergic reaction. The positive lymphocyte transformation caused by cobalt was also observed. Conclusions: 
Cobalt salts may induce occupational asthma. The mechanism of this asthma may be IgE-mediated. The cobalt-sensitized 
lymphocytes may play an important role in this disease.
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INTRODUCTION
Cobalt is a hard magnetic metal that is commonly used as a 
binder in cemented tungsten carbide, in the glass, printing, 
ceramic and photographic industries. Cobalt compounds 
are used as pigments, animal feed additives and foam sta-
bilizers [1,2]. Professions, in which cobalt-related respira-
tory diseases occur include diamond polishing, porcelain 
painting, tungsten carbide manufacturing and cobalt ex-
traction. The inspiration of dust containing cobalt leads to 
various respiratory symptoms, including irritation of the 
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upper respiratory tract, asthma, and a form of interstitial 
lung disease called “hard metal lung” [3,4]. This report 
details the initial and follow-up laboratory examinations 
of cobalt-induced occupational asthma with special refer-
ence to cobalt-induced changes in nasal washings and in 
lymphocyte proliferation.
The results of several studies on the course of occupation-
al asthma show that ventilation disorders, airway obstruc-
tion, and clinical symptoms may persist after cessation of 
exposure [1,5,6]. In this article, the authors present a case 
of cobalt asthma with the progression of clinical state after 
leaving the occupational exposure.
Case history
A 35-year-old man with a 2-year history of cough and 
dyspnea was admitted to the Department of Occupa-
tional Diseases, the Nofer Institute of Occupational 
Medicine in September 2000. He was a diamond pol-
ishing disc former. He had been working in hard metal 
industry since 1990 and had to quit his job 8 months 
ago because of respiratory disorders. His job comprised 
polishing of discs out of forms and clearing the form 
and the disc. He suffered from wheezing, shortness of 
breath and rhinitis, but could not precisely describe the 
onset of these symptoms. He used to smoke, but quit 
smoking in 1999 due to his disease. The patient had 
no history of asthma or allergic disorders in his family. 
Because of his symptoms he was ﬁrst admitted to the 
local hospital ward of internal diseases in January 2000, 
where he was attended by a general practitioner (GP), 
and treated with salmeterol xinafoate, salbutamol sul-
phate, and a combination of fenoterol hydrobromide 
with ipratropium bromide.
On his ﬁrst admission to the Department of Occupational 
Diseases (September 2000), the patient presented symp-
toms of dyspnea with wheezing. The chest was asymmet-
ric, due to lateral spinal curvature. The heart rate was 100 
per min.
Informed consent had been provided by the worker be-
fore the challenge studies with cobalt chloride salts were 
performed.
MATERIALS AND METHODS
Laboratory tests
The subject underwent a medical history, physical exami-
nation and pulmonary function testing by means of spi-
rometry.
Skin prick tests (SPTs) with a battery of the most com-
mon allergens (commercial set of Allergopharma, 
Germany) including: Dermatophagoides pteronyssinus, 
Dermatophagoides farinae, grass and trees I (alder, 
hazel, poplar, elm, willow) and II (birch, beech, oak, 
plane), moulds I (Alternaria tenuis, Botrytis cinerea, 
Cladosporium herbarum, Culvularia lunata, Helmintho-
sporium) and II (Aspergillus fumigatus, Mucor mucedo, 
Penicillium notatum, Pullularia pullulans, Rhizopus ni-
gricans, Serpula lacrymans), feathers and cobalt chlo-
ride (prick-by-prick) [4], and nickel chloride (prick-
by-prick) suspended in physiological saline solution at 
concentrations of 0.01%, 0.1% and 1% (the authors’ 
own method).
The negative control was allergen diluent and the posi-
tive one–histamine dihydrochloride solution at 1mg/ml. 
All tested sites were examined after 20 min and then after 
24 h respectively: a wheal of 3 mm larger than negative 
control was considered positive.
Total serum IgE level and the presence of speciﬁc IgE 
(RAST) for such common allergens as D. pteronyssinus and 
house dust mite were evaluated (Pharmacia, Sweden).
Total and differential white blood cell counts (WBCs) 
were determined before and every time after the nasal 
provocation with 0.05% solution with cobalt chloride.
Nasal provocation test
In the ﬁrst stage – the nasal provocation with placebo – 
phosphate-buffered saline solution (PBS) was performed, 
and after 3 days the nasal provocation was carried out with 
0.05% cobalt chloride in PBS (the authors’ own method).
Nasal lavage procedure
The subject underwent nasal lavage before the provoca-
tion and then 30 min, 4 and 24 h after the challenge with 
0.05% solution of cobalt chloride.
O R I G I N A L  P A P E R S     A. KRAKOWIAK, ET AL.  
IJOMEH 2005;18(2) 153
Before the provocation each nostril was washed 10 times 
with 6 ml of saline using a 5 ml syringe closely ﬁtting the 
nostril. Nasal washings were collected as mentioned above 
(before the provocation and then 30 min, 4 and 24 h after 
the provocation). All washings were always performed on 
the same side of the nasal cavity.
Centrifugation (10 min at 1000 rpm) of the nasal wash-
ings was performed to isolate the cell pellet and the su-
pernatant. The obtained sediment was washed with sterile 
phosphate-buffered saline (Dulbecco, Sigma, USA) and 
0.1% human serum albumin (HSA, Behringwerke A.G., 
Germany) and then suspended in 1 ml buffer with HSA. 
Subsequently, the cells were stained using: (a) the Turk 
method for leukocytes, (b) the Dunger method for eo-
sinophils, and (c) 0.06% toluidine blue in 30% ethanol for 
basophils (metachromatic cells). The cells were counted in 
a Fuchs-Rosenthal chamber. The number of cells in 1 ml 
of the recovered ﬂuid was determined.
The samples were further centrifuged at 2000 rpm for 
5 min, transferred onto a slide, and air-dried. The slides 
were stained following the Giemsa method. The differen-
tial cell count was performed on 200 cells/slide.
The supernatant total protein content was evaluated with 
the Lowry method [7].
Albumin concentration was measured using the “rocket” 
method of Laurell [8] (the assay ranged between 20 and 
200 µg/ml). The permeability index, i.e. the albumin to to-
tal protein ratio was calculated.
Bronchoscopy and bronchoalveolar lavage procedure
One bronchoscopy with bronchoalveolar lavage (BAL) 
was performed before the provocation. Bronchoscopy 
after the nasal provocation with cobalt chloride was not 
performed due to decrease in spirometric parameters af-
ter the challenge that persisted until 24 h after the provo-
cation.
Premedications included intramuscular atropine sulfate 
(1 mg) and diazepam (10 mg). Minimal quantities of 4% 
lidocaine were used for the airway anesthesia. A ﬁberoptic 
bronchoscope (BF 1T30; Olympus Corporation of Japan) 
was wedged in the lateral segment of the middle lobe and 
140 ml of sterile warmed 0.9% NaCl were inserted in 20 
ml portions and aspirated with about a 70% recovery, and 
then collected into a sterile siliconized glass vessel. The 
cytological smears were made from the bronchoalveolar 
lavage ﬂuid (BALF) cellular sediment with trypan blue 
(evaluation of cells number and viability). The lavage ﬂuid 
was centrifuged at 1400 g for 1 min, then concentrations of 
albumin, total protein and the permeability index, i.e. the 
albumin to total protein ratio were calculated. A cell count 
was performed using a Burker chamber. Cell staining was 
carried out by the Papenheim method. Differential cell 
counts were expressed in percentages.
Pulmonary function and histamine challenge testing
The whole nasal challenge time was 15 min. The positive 
response was deﬁned as at least 20% fall in forced expi-
ratory volume in one second (FEV1) from the baseline. 
Bronchial response was measured by monitoring of FEV1 
before, and then 5 min, 5 and 24 h after the provocation 
(Vicatest 2A, Mijnhardt, Holland).
Histamine challenge testing was evaluated according to 
Cockroft et al. [9] before the provocation.
Other evaluations included: blood laboratory tests, SPTs 
with cobalt chloride, spirometry and chest radiograph dur-
ing the next three hospitalizations in the Department of 
Occupational Diseases (twice in December 2002; one in 
March 2003).
Cell proliferation assay
Peripheral blood mononuclear cells (PBMCs) were isolat-
ed by centrifugation at 400 g, 21°C for 30 min on the gra-
dient of Histopaque (1.077 g/ml). Cells were suspended 
at the concentration of 2 million cells per 1 ml of culture 
medium (RPMI 1640, 10% FCS, streptomycine, gentamy-
cine, penicilline, 2 mM L-glutamine).
Cells were transfered to 24 well plates, and each well con-
sisted of 2 million cells in 1 ml. Cells were set up in the 
wells to include 3 different concentrations of the antigen, 
the negative control (cells in culture medium) and the pos-
itive control (mitogen stimulated). PBMCs were cultured 
for total of 10 days.
Cell proliferation analyses were carried out using the 
manufacturer’s kit (Roche) and according to its protocol 
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with a slight modiﬁcation. The modiﬁcation that we have 
introduced concerned the use of relatively larger amounts 
of reagents per well, since we utilized a higher number of 
cells and volume of the medium in cell culture. The test 
was based on the incorporation of bromo-deoxyuridine 
into DNA of proliferating cells. The BrdU was added 18 h 
before the completion of the test and detected by anti-
BrdU antibodies conjugated with horseradish peroxidase. 
The ﬁnal results of the developing color reaction was mea-
sured on a spectrophotometer (Bio-Rad).
RESULTS
On admission, the patient’s lung function parameters 
(before the nasal provocation with cobalt chloride) were: 
FVC – 5.08 (82%) and FEV1 – 3.15 (63%). DLCO mea-
sured during the ﬁrst hospitalization was within the nor-
mal range.
Blood laboratory ﬁndings were within the normal range, 
MCV and MCH were slightly increased. The following 
parameters were found to be normal: glucose, cholesterol, 
urea, clotting parameters, creatinine, transaminases, bili-
rubine and triglycerides.
The authors did not ﬁnd any abnormalities in the chest ra-
diograph and computerized tomography (CT) scans. USG 
of the abdomen was normal, except for slightly enlarged 
liver.
Total IgE level was 176 kU/l, therefore the patient was 
considered to be atopic. SPTs with a battery of the most 
common allergens were found to be negative. No specif-
ic IgE to D. pteronyssinus and to house dust mite were 
found.
The results of SPTs with cobalt chloride appeared to be 
positive for all applied solutions, while SPTs with nickel 
chloride were negative.
Cellular and biochemical ﬁndings in nasal lavage after 
the speciﬁc challenge test
Allergen challenge caused an increase in the proportion 
of eosinophils after 4 and 24 h and in the proportion of 
basophils after 24 h, but no changes were observed in the 
proportion of neutrophils (Fig. 1).
The speciﬁc challenge induced the increase in the percent-
age of albumin (the mucosal/ascular permeability index) 
only after 24 h (Fig. 1).
No changes in the morphological and biochemical ﬁndings 
were observed at any time after the challenge with placebo 
(Fig. 2).
Cellular populations in BALF before the speciﬁc chal-
lenge test are presented in Table 1. We were not able to 
perform bronchoscopy after the nasal challenge with co-
balt chloride due to the clinical state of the patient.
Fig. 1. The proportion of cells and the level of albumin in nasal lavage 
ﬂuid before and after the speciﬁc challenge test (cobalt chloride).
Fig. 2. The proportion of cells and the level of albumin in nasal lavage 
ﬂuid before and after the placebo challenge.
Table 1. Cellular and biochemical ﬁndings in bronchoalveolar lavage 
ﬂuid before the nasal challenge with cobalt chloride.
Cells Before the nasal challenge with cobalt chloride (%)
Macrophages
Monocytes
Neutrophils
Eosinophils
Lymphocytes
Basophils
78.5
6.5
1.9
6.5
5.6
1.0
Albumin 6.5
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Pulmonary function and airway hyperreactivity
The results of spirometric parameters during the patient’s 
hospitalizations are presented in Table 2.
Allergen provocation caused a decrease in FEV1 and peak 
respiratory ﬂow (PEF) during the late allergic reaction (Figs. 
3 and 4). No signiﬁcant changes in FEV1 and PEF were no-
ticed after the challenge with placebo (Figs. 3 and 4).
Histamine speciﬁc inhalatory challenge test was per-
formed only before the speciﬁc nasal provocation (PC20–
3.8 mg/ml). We were not able to perform this test after the 
provocation with cobalt chloride due to the clinical state 
of the patient.
We were also able to perform the histamine speciﬁc in-
halatory challenge test during the second hospitalization 
(PC20 3.2 mg/ml) (Table 3).
When seen on the next hospitalization in the Department, 
the patient was still breathless, his condition had worsened 
considerably with dyspnea at the lightest effort and even 
at rest. Pulmonary function tests revealed the signiﬁcant 
decrease in FEV1 (Table 2).
The patient’s airway hyperresponsiveness worsened de-
spite complete avoidance of cobalt chloride exposure and 
continuous administration of anti-asthmatic medication.
Laboratory data showed normal hematologic parameters, 
and the chest radiographs did not show progressive chang-
es compared with those on the ﬁrst radiograph.
On the patient’s ﬁrst examination in our Department cor-
ticosteroid treatment was initiated in a dose of 32 mg. The 
dose was tapered to 8 mg on his discharge.
He was advised to discontinue exposure to cobalt chloride 
and to take anti-asthma medication.
Cell proliferation assay
The results are presented as a relative increase in pro-
liferation above the control which constituted cells sus-
Fig. 3. FEV1 changes before and after the nasal challenge with cobalt 
chloride and placebo.
Fig. 4. PEF changes before and after the nasal challenge with cobalt 
chloride and placebo.
Table 2. Pulmonary function tests – a follow up study
Number
N1 N2 N3 N4
A P %P A P %P A P %P A P %P
FVC (L) 5.08 6.15 82 4.98 6.15 80 4.99 6.15 94 5.70 6.15 93
FEV1 (L/s) 3.15 5.01 63 3.10 5.01 61 3.0 5.01 59 2.98 5.01 59
A – actual;          P – predicted;             N1 – the ﬁrst hospitalization in the Department of Occupational Diseases;
N2 – the second hospitalization;          N3 – the third hospitalization;          N4 – the fourth hospitalization.
Table 3. Follow-up results – current medication and PC20
Avoidance of 
occupational 
exposure
Follow-up 
period
(months)
Hista-
mine 
PC20
Current medication
Patient Yes 12 3.2
Bronchodilatator
 + oral and inhaled  
corticosteroids
Patient Yes 14 (-)
Patient Yes 24 (-)
(-) – Not done, because of the patient’s clinical state.
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pended in culture media only. The response was dose-
dependent and reached an optimum at 100 ng/ml of 
Co(NO3)2  (Fig. 5).
DISCUSSION
Cobalt has been regarded as an agent responsible for the 
development of asthmatic reactions in workers exposed 
to hard metal dust [1,2,4]. The known ability of cobalt to 
sensitize the respiratory tract is still discussed. Occupa-
tional asthma in hard metal workers is characterized by 
wheezing, cough and shortness of breath. In the majority 
of subjects with diagnosed occupational asthma induced 
by cobalt, the asthmatic response develops during the late 
reaction.
The appearance of late allergic reaction observed in our 
study after the nasal provocation with cobalt chloride is 
compatible with that found in the cases with occupational 
asthma induced by low-molecular weight substances.
The clinical symptoms and work history of our patient sug-
gested that he was suffering from asthma with hypersensi-
tivity to cobalt. The diagnosis was based on the following 
clinical ﬁndings: SPTs results, the positive bronchial re-
sponse to the nasal challenge testing with cobalt chloride 
and the absence of abnormalities in x-ray ﬁlms and CT 
scans.
Our patient was considered to be atopic. Atopy is a well 
documented risk factor for the development of occupa-
tional allergy due to high-molecular weight allergens such 
as ﬂour, laboratory animal allergens and some low-molec-
ular weight substances (e.g., nickel salts and trimellitic an-
hydride) [10–13]. We did not perform the patch test with 
cobalt salts, as in our opinion this test is not a valuable 
method for the diagnosis of occupational asthma [2,14].
Typically, the nasal allergen challenge induces a prolonged 
increase in the number of eosinophils and basophils and 
in the albumin/protein ratio [15,16]. In the present study 
we also observed similar morphological and biochemical 
changes after the nasal challenge with cobalt chloride.
We did not ﬁnd signiﬁcant changes in the percentage of 
neutrophils after the nasal challenge with cobalt chloride 
either in the early or in the late allergic reactions. Other 
studies have described an increase in neutrophil chemotac-
tic activity associated with activation of these cells during 
asthmatic reactions provoked by diisocyanates [17,18].
The result of BALF performed in our patient was normal 
before the nasal challenge with cobalt chloride. We as-
sume, however, that these cells should have accumulated 
in the respiratory tract after the speciﬁc challenge test, like 
in the nasal lavage, as we believe that the ongoing inﬂam-
mation in the nose reﬂect the same process in the lower 
part of the respiratory tract. Because of the clinical state 
of the patient, we were not able to perform bronchoscopy 
with BAL after the nasal provocation with cobalt chloride 
and during the next hospitalization in our Department.
One could expect that after cessation of occupational 
exposure to the particular sensitizing agent, the patient 
should have recovered. Unfortunately such a course of the 
disease can be observed only in a few cases of occupational 
asthma [19]. Some patients show persistent asthma even 
after total removal from occupational exposure, whereas 
others recover completely with normalization of their 
nonspeciﬁc bronchial reactivity. We noticed the increased 
bronchial hyperreactivity to histamine in the patient also 
during his second hospitalization in our Department. This 
is also likely to be due to persistent immunologic sensi-
tization to the occupational agent, which was proved by 
positive SPTs with cobalt chloride during the second hos-
pitalization.
In addition, we noticed the positive lymphocyte trans-
formation to cobalt, thus suggesting the immunological 
mechanism of bronchial asthma caused by this low-mo-
lecular weight allergen.
Fig. 5. Proliferation of PBMCs in response to cobalt.
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The clinical state of our patient at ﬁrst examination dif-
fered from that at re-examinations. His condition had 
worsened considerably with dyspnea at the lightest effort 
and even at rest. The use of oral corticosteroids was in-
creased from 32 mg during the ﬁrst examination per day to 
48 mg during the last hospitalization in the Department.
Also a daily dose of beta agonists was increased from 4.12 
puffs per day during the ﬁrst hospitalization to 6.78 puffs 
per day on average during the last hospitalization.
CONCLUSIONS
Although numerous reports on immunoallergic origin of 
cobalt sensitivity have been published, it seems that the 
mechanism by which this agent induces bronchial asthma 
is still unknown. Morphological and biochemical changes 
in the nasal washings after the nasal challenge resemble 
the features of IgE-mediated allergic inﬂammation, espe-
cially the inﬂux of eosinophils and subsequent increase in 
mucosal permeability. However, several features revealed 
in the present study, especially in nasal washings follow-
ing the provocation with cobalt chloride, differ from those 
seen after the provocation with high-molecular weight 
allergens. The main difference applies to the kinetics of 
changes. Signiﬁcant changes in nasal washings could be 
detected 4 h after the cobalt chloride provocation that ac-
companied bronchoconstriction which peaked 24 h later. 
In comparison with high-molecular weight allergens, these 
changes are observed earlier, during the immediate re-
sponse.
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